Recently, Wang et al. demonstrated that simvastatin can activate NLRP3-caspase-1 pathway to induce pyroptosis in non-small cell lung cancer (NSCLC) cell lines and mouse models 109. Here, CASP1 is linked to non-small cell lung carcinoma.